Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00167414 · ClinicalTrials.gov registry record · NA
Study for Using Radiosurgery on Limited Metastases of Breast Cancer
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00167414 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 49 participants.
The verdict
NCT00167414, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therapy, or chemotherapy alone or in any combination. A second purpose of this study is to determine if the levels of a special type of protein (called cytokines) found in the blood are related to the quality of life while on this treatment.
Interventions
- PROCEDURE Hypofractionated Stereotactic Body Radiation Therapy
- RADIATION Hypofractionated Stereotactic Body Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2000-12 |
| Est. Completion | 2016-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00167414
The ClinicalTrials.gov registry entry for NCT00167414 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypofractionated Stereotactic Body Radiation Therapy is the first listed.
NCT00167414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00167414 about?
NCT00167414 is a clinical study titled "Study for Using Radiosurgery on Limited Metastases of Breast Cancer". The purpose of this study is to evaluate whether radiosurgery, along with standard chemotherapy, immunotherapy (the treatment of cancer by modulating the immune system and immune response), or hormonal therapy, affects the quality and length of life. The standard therapy is surgery, radiation therap...
What is the current status of trial NCT00167414?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2000-12. Estimated completion is 2016-11-01.
What interventions are being tested in trial NCT00167414?
The interventions under investigation include: Hypofractionated Stereotactic Body Radiation Therapy (PROCEDURE), Hypofractionated Stereotactic Body Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00167414?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.